MTCR Shares Outstanding History Table | ||||||||||||||||||||||
Also see: MTCR Market Cap History MTCR YTD Return |
MTCR Shares Outstanding History Table | ||||||||||||||||||||||
Also see: MTCR Market Cap History MTCR YTD Return |
MTCR Shares Outstanding History Chart | |||||||||||||||||||||||
+25.98% CAGR Mouse over chart for data details
|
MTCR Stock Price Chart |
About Metacrine Inc |
Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with gastrointestinal, or GI, diseases. Co.'s program, MET642, targets the farnesoid X receptor, or FXR, which is central to modulating GI and liver diseases. Co. is developing another FXR agonist, MET409, for the treatment of non-alcoholic steatohepatitis, or NASH, a liver disease characterized by excess liver fat, inflammation and fibrosis. Co. is also developing small molecule inhibitors of hydroxysteroid dehydrogenase 17b13, or HSD17ß13, for the treatment of NASH. HSD17ß13 is a genetically validated target for liver disease. We show 10 historical shares outstanding datapoints in our coverage of MTCR's shares outstanding history. Understanding the changing numbers of MTCR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MTCR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MTCR by allowing them to research MTCR shares outstanding history as well as any other stock in our coverage universe. |
MTCR Current Stock Quote |
Free MTCR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
MTCR Share Performance |
Shares Outstanding Peers |
Metacrine (MTCR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MTEM Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.